144 related articles for article (PubMed ID: 21737956)
1. Effects of quinidine on the action potential duration restitution property in the right ventricular outflow tract in patients with brugada syndrome.
Ashino S; Watanabe I; Kofune M; Nagashima K; Ohkubo K; Okumura Y; Mano H; Nakai T; Kunimoto S; Kasamaki Y; Hirayama A
Circ J; 2011; 75(9):2080-6. PubMed ID: 21737956
[TBL] [Abstract][Full Text] [Related]
2. Abnormal action potential duration restitution property in the right ventricular outflow tract in Brugada syndrome.
Ashino S; Watanabe I; Kofune M; Nagashima K; Ohkubo K; Okumura Y; Nakai T; Kasamaki Y; Hirayama A
Circ J; 2010 Apr; 74(4):664-70. PubMed ID: 20190424
[TBL] [Abstract][Full Text] [Related]
3. Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome.
Morita H; Zipes DP; Morita ST; Wu J
Heart Rhythm; 2007 Jan; 4(1):66-74. PubMed ID: 17198993
[TBL] [Abstract][Full Text] [Related]
4. Ventricular repolarization restitution properties in patients exhibiting type 1 Brugada electrocardiogram with and without inducible ventricular fibrillation.
Hayashi M; Takatsuki S; Maison-Blanche P; Messali A; Haggui A; Milliez P; Leenhardt A; Extramiana F
J Am Coll Cardiol; 2008 Mar; 51(12):1162-8. PubMed ID: 18355653
[TBL] [Abstract][Full Text] [Related]
5. Action potential alternans in the right ventricular outflow tract in a patient with asymptomatic Brugada syndrome.
Kofune M; Watanabe I; Ashino S; Ohkubo K; Okumura Y; Kofune T; Nakai T; Hirayama A
Circ J; 2009 Mar; 73(3):580-3. PubMed ID: 19075522
[TBL] [Abstract][Full Text] [Related]
6. Endocardial electrograms from the right ventricular outflow tract after induced ventricular fibrillation in patients with Brugada syndrome.
Ohkubo K; Watanabe I; Takagi Y; Okumura Y; Ashino S; Kofune M; Kofune T; Shindo A; Sugimura H; Nakai T; Kunimoto S; Kasamaki Y; Saito S; Hirayama A
Circ J; 2007 Aug; 71(8):1258-62. PubMed ID: 17652891
[TBL] [Abstract][Full Text] [Related]
7. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
[TBL] [Abstract][Full Text] [Related]
8. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
Belhassen B; Glick A; Viskin S
Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
[TBL] [Abstract][Full Text] [Related]
9. Site-specific arrhythmogenesis in patients with Brugada syndrome.
Morita H; Fukushima-Kusano K; Nagase S; Takenaka-Morita S; Nishii N; Kakishita M; Nakamura K; Emori T; Matsubara H; Ohe T
J Cardiovasc Electrophysiol; 2003 Apr; 14(4):373-9. PubMed ID: 12741708
[TBL] [Abstract][Full Text] [Related]
10. Right ventricular histological substrate and conduction delay in patients with Brugada syndrome.
Ohkubo K; Watanabe I; Okumura Y; Takagi Y; Ashino S; Kofune M; Sugimura H; Nakai T; Kasamaki Y; Hirayama A; Morimoto S
Int Heart J; 2010 Jan; 51(1):17-23. PubMed ID: 20145346
[TBL] [Abstract][Full Text] [Related]
11. Repolarization heterogeneity in the right ventricular outflow tract: correlation with ventricular arrhythmias in Brugada patients and in an in vitro canine Brugada model.
Morita H; Zipes DP; Fukushima-Kusano K; Nagase S; Nakamura K; Morita ST; Ohe T; Wu J
Heart Rhythm; 2008 May; 5(5):725-33. PubMed ID: 18452878
[TBL] [Abstract][Full Text] [Related]
12. Transient local changes in right ventricular monophasic action potentials due to ajmaline in a patient with Brugada Syndrome.
Eckardt L; Kirchhof P; Johna R; Breithardt G; Borggrefe M; Haverkamp W
J Cardiovasc Electrophysiol; 1999 Jul; 10(7):1010-5. PubMed ID: 10413381
[TBL] [Abstract][Full Text] [Related]
13. Action potential alternans and irregular dynamics in quinidine-intoxicated ventricular muscle cells. Implications for ventricular proarrhythmia.
Karagueuzian HS; Khan SS; Hong K; Kobayashi Y; Denton T; Mandel WJ; Diamond GA
Circulation; 1993 May; 87(5):1661-72. PubMed ID: 8491022
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects of bepridil on ventricular repolarization in humans. Inhomogeneous prolongation of the action potential duration vs flattening of its restitution kinetics.
Osaka T; Yokoyama E; Kushiyama Y; Hasebe H; Kuroda Y; Suzuki T; Kodama I
Circ J; 2009 Sep; 73(9):1612-8. PubMed ID: 19609043
[TBL] [Abstract][Full Text] [Related]
15. Restitution metrics in Brugada syndrome: a systematic review and meta-analysis.
Tse G; Lee S; Gong M; Mililis P; Asvestas D; Bazoukis G; Roever L; Jeevaratnam K; Hothi SS; Li KHC; Liu T; Letsas KP
J Interv Card Electrophysiol; 2020 Mar; 57(2):319-327. PubMed ID: 31836966
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine.
Bouzeman A; Traulle S; Messali A; Extramiana F; Denjoy I; Narayanan K; Marijon E; Hermida JS; Leenhardt A
Europace; 2014 Apr; 16(4):572-7. PubMed ID: 24068450
[TBL] [Abstract][Full Text] [Related]
17. Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome.
Szél T; Koncz I; Antzelevitch C
Heart Rhythm; 2013 Nov; 10(11):1720-7. PubMed ID: 23911896
[TBL] [Abstract][Full Text] [Related]
18. Spatial dispersion of action potential duration restitution kinetics is associated with induction of ventricular tachycardia/fibrillation in humans.
Pak HN; Hong SJ; Hwang GS; Lee HS; Park SW; Ahn JC; Moo Ro Y; Kim YH
J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1357-63. PubMed ID: 15610278
[TBL] [Abstract][Full Text] [Related]
19. Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs.
Belhassen B; Rahkovich M; Michowitz Y; Glick A; Viskin S
Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1393-402. PubMed ID: 26354972
[TBL] [Abstract][Full Text] [Related]
20. Abnormal atrial repolarization and depolarization contribute to the inducibility of atrial fibrillation in Brugada syndrome.
Kofune M; Watanabe I; Ohkubo K; Ashino S; Okumura Y; Nagashima K; Nakai T; Kasamaki Y; Hirayama A
Int Heart J; 2010 May; 51(3):159-65. PubMed ID: 20558904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
